An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model
Abstract Hematopoietic stem and progenitor cells (HSPCs) can establish a long‐lasting microglia‐like progeny in the central nervous system of properly myeloablated hosts. We exploited this approach to treat the severe CLN1 neurodegenerative disorder, which is the most aggressive form of neuronal cer...
Saved in:
| Main Authors: | Marco Peviani, Sabyasachi Das, Janki Patel, Odella Jno‐Charles, Rajesh Kumar, Ana Zguro, Tyler D Mathews, Paolo Cabras, Rita Milazzo, Eleonora Cavalca, Valentina Poletti, Alessandra Biffi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202215968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trehalose Ameliorates Zebrafish Emotional and Social Deficits Caused by CLN8 Dysfunction
by: Rosario Licitra, et al.
Published: (2025-01-01) -
The Batten disease gene Cln3 is required for the activation of intestinal stem cell during regeneration via JAK/STAT signaling in Drosophila
by: Zihua Yu, et al.
Published: (2025-01-01) -
Maculopathy and adult‐onset ataxia in patients with biallelic MFSD8 variants
by: Sigurd Dobloug, et al.
Published: (2024-08-01) -
Hematopoietic stem cell discovery: unveiling the historical and future perspective of colony-forming units assay
by: Nur Afizah Yusoff, et al.
Published: (2025-01-01) -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Rafael de la Camara
Published: (2016-06-01)